Nonprofit drug developer in uphill battle against Trump administration contraception rule change


Medicines360 is pushing its low-cost IUD into African nations while its U.S. market faces pressure from a potential change in rules for a federal program.

Previous There are more female-led startups than ever. But they still face problems like investor bias
Next How an East Bay drug maker pivoted from opioids to the cusp of a seizure drug approval